Determinants of serum fibroblast growth factor-23 (FGF-23) in chronic kidney disease

被引：0
|
作者：
Manghat, P. [1 ]
Cheung, J. [1 ]
MacDonald, D. [1 ]
Asgari, E. [2 ]
Goldsmith, D. J. A. [2 ]
Wierzbicki, A. S. [1 ]
Fogelman, I. [3 ]
Hampson, G. [1 ]
机构：
[1] St Thomas Hosp, Dept Chem Pathol, London, England
[2] Guys Hosp, Renal Unit, London SE1 9RT, England
[3] Guys Hosp, Dept Nucl Med, London SE1 9RT, England
来源：
CALCIFIED TISSUE INTERNATIONAL | 2008年 / 83卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：21 / 21
页数：1
相关论文
共 50 条
  • [1] Fibroblast growth factor-23 (FGF-23) in children with chronic kidney disease.
    Price, H. E.
    Langman, C. B.
    Brooks, E. R.
    Fathallah-Shaykh, S.
    Bobrowski, A.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S47 - S47
  • [2] Prediction of Renal Disease Progression in Children with Chronic Kidney Disease by Fibroblast Growth Factor-23 (FGF-23)
    Wuehl, Elke
    Ardissino, Gianluigi
    Urasinski, Tomasz
    Jankauskiene, Augustina
    Peco-Antic, Amira
    Caliskan, Salim
    Schaefer, Franz
    PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1492 - 1492
  • [3] Fibroblast growth factor-23 (FGF-23) predicts renal failure progression in children with chronic kidney disease
    Wuehl, E.
    Ardissino, G.
    Urasinski, T.
    Jankauskiene, A.
    Peco-Antic, A.
    Caliskan, S.
    Schaefer, F.
    PEDIATRIC NEPHROLOGY, 2011, 26 (09) : 1576 - 1576
  • [4] FGF-23 (Fibroblast Growth Factor-23) and Cardiorenal Interactions
    Ivey-Miranda, Juan B.
    Stewart, Brendan
    Cox, Zachary L.
    McCallum, Wendy
    Maulion, Christopher
    Gleason, Olyvia
    Meegan, Grace
    Amatruda, Jonathan G.
    Moreno-Villagomez, Julieta
    Mahoney, Devin
    Turner, Jeffrey M.
    Wilson, F. Perry
    Estrella, Michelle M.
    Shlipak, Michael G.
    Rao, Veena S.
    Testani, Jeffrey M.
    CIRCULATION-HEART FAILURE, 2021, 14 (11) : E008385
  • [5] Serum troponin-I as a marker of fibroblast growth factor-23 (FGF-23) cardiotoxic effect, in patients with chronic kidney disease
    Taranova, M. V.
    Milovanova, L. Yu.
    Kozlovskaya , L. V.
    Milovanova, S. Yu.
    Androsova, T. V.
    Zubacheva, D. O.
    Lebedeva, M. V.
    Dobrosmyslov, I. A.
    Kozlov, V. V.
    Kuchieva, A. M.
    Li, O. A.
    Reshetnikov, V. A.
    TERAPEVTICHESKII ARKHIV, 2019, 91 (06) : 85 - 92
  • [6] FIBROBLAST GROWTH FACTOR 23 (FGF-23) IN FELINE CHRONIC KIDNEY DISEASE.
    Geddes, R. F.
    Finch, N. C.
    Elliott, J.
    Syme, H. M.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2011, 25 (03) : 720 - 721
  • [7] Serum Fibroblast Growth Factor-23 (FGF-23) and Fracture Risk in Elderly Men
    Mirza, Majd Ai
    Karlsson, Magnus K.
    Mellstrom, Dan
    Orwoll, Eric
    Ohlsson, Claes
    Ljunggren, Osten
    Larsson, Tobias E.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (04) : 857 - 864
  • [8] Serum fibroblast growth factor 23 (FGF-23): associations with hyperphosphatemia and clinical staging of feline chronic kidney disease
    Lin, Jiabao
    Lin, Luqi
    Chen, Siyu
    Yu, Lifang
    Chen, Songjie
    Xia, Zhaofei
    JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION, 2021, 33 (02) : 288 - 293
  • [9] Instability of fibroblast growth factor-23 (FGF-23): Implications for clinical studies
    Smith, Edward R.
    Ford, Martin L.
    Tomlinson, Laurie A.
    Weaving, Gary
    Rocks, Bernard F.
    Rajkumar, Chakravarthi
    Holt, Stephen G.
    CLINICA CHIMICA ACTA, 2011, 412 (11-12) : 1008 - 1011
  • [10] Increased serum fibroblast growth factor-23 (FGF-23) and bone turnover in patients with osteoarthritis of knee
    Zhou, Wu
    Liu, Guo-Hui
    Yang, Shu-Hua
    Ye, Shu-Nan
    Wang, Jing
    Liu, Xian-Zhe
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 1630 - 1638
12345